Study S000250

Comparison Of Two Triple Hypoglycemic Regimens In Achieving Glycemic Control And Diabetes Remission In Hospitalized Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Multicenter, Randomized, Clinical Study

ClinicalTrials.gov record

Registration

Registration: NCT07374328
Acronym: TRED
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1; PHASE2
Masking: SINGLE
Status: RECRUITING
Enrollment: 240
Start: 2025-06-01
Primary completion: 2026-05-31
Lead sponsor: Second Affiliated Hospital of Guangzhou Medical University
Conditions: Type 2 Diabetes
Interventions: DRUG:Semaglutide (1 Mg Dose); DRUG:Sitagliptin (DPP4 inhibitor)
Results posted: FALSE

Registered primary outcomes

Diabetes remission rate [From enrollment to the end of follow-up at 11 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.